Hans Peter Hasler
Chairman of the Board of Directors since 2009, Member of the Compensation Committee, Swiss national
Since 2017 CEO of Vicarius Pharma. Prior to this, international management positions at Wyeth Pharmaceuticals (1993 to 2001), Biogen and Biogen Idec (2001 to 2009), as well as Elan Corporation (2012 to 2013)
Chairman of the Board of Directors MIAC AG since 2012. Member of the Board of Directors Minerva Neurosciences since 2017, member of the Board of Directors Shield Therapeutics plc since 2018.